Association between vitamin D hypovitaminosis and severe forms of COVID-19
Authors
Ilinčić, BranislavaTomić Naglić, Dragana
Čabarkapa, Velibor
Bajkin, Ivana
Plećaš Đurić, Aleksandra
Kolarski, Ivor
Bojović, Marko
Urošević, Ivana
Stokić, E.
Isenović, Esma R.

Article (Published version)
Metadata
Show full item recordAbstract
Objective: Hypovitaminosis D may be associated with an increased susceptibility to infection, more severe COVID-19 forms, and a higher risk of death. The objective of this study was to investigate any possible connections between vitamin D status [as measured by serum 25-hydroxyvitamin D (25(OH)D) levels] and COVID-19 severity. Patients and methods: In 2021, a cross-sectional study of consecutive adult COVID-19 patients was conducted. Anthropometric data, comorbidities, hospital setting, length of stay, respiratory support, outcome data, and vitamin D status were all evaluated. Results: The length of hospitalization among participants (n = 74; mean age 57.64 ± 17.83 years, 55.4% male) was 18.58 ± 10 days, the majority of the hospital setting was a medical ward (67.6%), and the respiratory support in the form of mechanical ventilation was represented by 12.2%. Hypertension (54.1%), obesity (64.9%), and overweight (64.9%) were the most common cardiometabolic risk factors. In the study ...group, 44.6% of participants had severe vitamin D deficiency (< 30 nmol/l), while 8.1% had vitamin D insufficiency (50 - 74.9 nmol/l). Furthermore, patients with severe COVID-19 (semi-intensive care unit, intensive care unit) had significantly lower serum 25(OH)D levels (32.9 vs. 20.5 nmol/l; p = 0.007). Participants with severe vitamin D deficiency were older and had more prevalent hypertension, requiring mechanical ventilation; 24.2% experienced a fatal outcome. Conclusions: Severe vitamin D deficiency may contribute significantly to the influence of other cardiometabolic risk factors in COVID-19.
Keywords:
COVID-19 / Vitamin D deficiency / ICU / Cardiovascular riskSource:
European review for medical and pharmacological sciences, 2023, 27, 11, 5318-5326Funding / projects:
DOI: 10.26355/eurrev_202306_32651
ISSN: 1128-3602
WoS: 001047061000022
Scopus: 2-s2.0-85163902384
Collections
Institution/Community
VinčaTY - JOUR AU - Ilinčić, Branislava AU - Tomić Naglić, Dragana AU - Čabarkapa, Velibor AU - Bajkin, Ivana AU - Plećaš Đurić, Aleksandra AU - Kolarski, Ivor AU - Bojović, Marko AU - Urošević, Ivana AU - Stokić, E. AU - Isenović, Esma R. PY - 2023 UR - https://vinar.vin.bg.ac.rs/handle/123456789/11569 AB - Objective: Hypovitaminosis D may be associated with an increased susceptibility to infection, more severe COVID-19 forms, and a higher risk of death. The objective of this study was to investigate any possible connections between vitamin D status [as measured by serum 25-hydroxyvitamin D (25(OH)D) levels] and COVID-19 severity. Patients and methods: In 2021, a cross-sectional study of consecutive adult COVID-19 patients was conducted. Anthropometric data, comorbidities, hospital setting, length of stay, respiratory support, outcome data, and vitamin D status were all evaluated. Results: The length of hospitalization among participants (n = 74; mean age 57.64 ± 17.83 years, 55.4% male) was 18.58 ± 10 days, the majority of the hospital setting was a medical ward (67.6%), and the respiratory support in the form of mechanical ventilation was represented by 12.2%. Hypertension (54.1%), obesity (64.9%), and overweight (64.9%) were the most common cardiometabolic risk factors. In the study group, 44.6% of participants had severe vitamin D deficiency (< 30 nmol/l), while 8.1% had vitamin D insufficiency (50 - 74.9 nmol/l). Furthermore, patients with severe COVID-19 (semi-intensive care unit, intensive care unit) had significantly lower serum 25(OH)D levels (32.9 vs. 20.5 nmol/l; p = 0.007). Participants with severe vitamin D deficiency were older and had more prevalent hypertension, requiring mechanical ventilation; 24.2% experienced a fatal outcome. Conclusions: Severe vitamin D deficiency may contribute significantly to the influence of other cardiometabolic risk factors in COVID-19. T2 - European review for medical and pharmacological sciences T1 - Association between vitamin D hypovitaminosis and severe forms of COVID-19 VL - 27 IS - 11 SP - 5318 EP - 5326 DO - 10.26355/eurrev_202306_32651 ER -
@article{ author = "Ilinčić, Branislava and Tomić Naglić, Dragana and Čabarkapa, Velibor and Bajkin, Ivana and Plećaš Đurić, Aleksandra and Kolarski, Ivor and Bojović, Marko and Urošević, Ivana and Stokić, E. and Isenović, Esma R.", year = "2023", abstract = "Objective: Hypovitaminosis D may be associated with an increased susceptibility to infection, more severe COVID-19 forms, and a higher risk of death. The objective of this study was to investigate any possible connections between vitamin D status [as measured by serum 25-hydroxyvitamin D (25(OH)D) levels] and COVID-19 severity. Patients and methods: In 2021, a cross-sectional study of consecutive adult COVID-19 patients was conducted. Anthropometric data, comorbidities, hospital setting, length of stay, respiratory support, outcome data, and vitamin D status were all evaluated. Results: The length of hospitalization among participants (n = 74; mean age 57.64 ± 17.83 years, 55.4% male) was 18.58 ± 10 days, the majority of the hospital setting was a medical ward (67.6%), and the respiratory support in the form of mechanical ventilation was represented by 12.2%. Hypertension (54.1%), obesity (64.9%), and overweight (64.9%) were the most common cardiometabolic risk factors. In the study group, 44.6% of participants had severe vitamin D deficiency (< 30 nmol/l), while 8.1% had vitamin D insufficiency (50 - 74.9 nmol/l). Furthermore, patients with severe COVID-19 (semi-intensive care unit, intensive care unit) had significantly lower serum 25(OH)D levels (32.9 vs. 20.5 nmol/l; p = 0.007). Participants with severe vitamin D deficiency were older and had more prevalent hypertension, requiring mechanical ventilation; 24.2% experienced a fatal outcome. Conclusions: Severe vitamin D deficiency may contribute significantly to the influence of other cardiometabolic risk factors in COVID-19.", journal = "European review for medical and pharmacological sciences", title = "Association between vitamin D hypovitaminosis and severe forms of COVID-19", volume = "27", number = "11", pages = "5318-5326", doi = "10.26355/eurrev_202306_32651" }
Ilinčić, B., Tomić Naglić, D., Čabarkapa, V., Bajkin, I., Plećaš Đurić, A., Kolarski, I., Bojović, M., Urošević, I., Stokić, E.,& Isenović, E. R.. (2023). Association between vitamin D hypovitaminosis and severe forms of COVID-19. in European review for medical and pharmacological sciences, 27(11), 5318-5326. https://doi.org/10.26355/eurrev_202306_32651
Ilinčić B, Tomić Naglić D, Čabarkapa V, Bajkin I, Plećaš Đurić A, Kolarski I, Bojović M, Urošević I, Stokić E, Isenović ER. Association between vitamin D hypovitaminosis and severe forms of COVID-19. in European review for medical and pharmacological sciences. 2023;27(11):5318-5326. doi:10.26355/eurrev_202306_32651 .
Ilinčić, Branislava, Tomić Naglić, Dragana, Čabarkapa, Velibor, Bajkin, Ivana, Plećaš Đurić, Aleksandra, Kolarski, Ivor, Bojović, Marko, Urošević, Ivana, Stokić, E., Isenović, Esma R., "Association between vitamin D hypovitaminosis and severe forms of COVID-19" in European review for medical and pharmacological sciences, 27, no. 11 (2023):5318-5326, https://doi.org/10.26355/eurrev_202306_32651 . .